Search research articles
Contact Us
Filters
Showing results (31-40 of 136) with videos related to
Page
of 14
Sort By:
Investigational New Drugs
|
November 26, 2009
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618
Susanne M Arnold, James Moon, Stephen K Williamson, et al.
BMJ Open Sport & Exercise Medicine
|
November 2, 2019
Can marathon running improve knee damage of middle-aged adults? A prospective cohort study
Laura Maria Horga, Johann Henckel, Anastasia Fotiadou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 11, 2017
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
Anne S Tsao, James Moon, Ignacio I Wistuba, et al.
Cancer
|
June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007
Francis P Worden, James Moon, Wolfram Samlowski, et al.
Cancer
|
April 10, 2004
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study
Robert P Whitehead, James Moon, S Spence McCachren, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Gynecologic Oncology
|
September 18, 2010
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study
Leslie M Randall, Bradley J Monk, James Moon, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
September 23, 2009
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group
George H Yoo, James Moon, Michael Leblanc, et al.
Expert Review of Cardiovascular Therapy
|
March 4, 2017
Invasive or non-invasive imaging for detecting high-risk coronary lesions?
Kush Patel, Jason Tarkin, Patrick W Serruys, et al.
Cancer Medicine
|
October 11, 2017
High frequency of brain metastases after adjuvant therapy for high-risk melanoma
Wolfram E Samlowski, James Moon, Merle Witter, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 136) with videos related to
Sort By:
Page
of 14
Investigational New Drugs
|
November 26, 2009
Phase II evaluation of eribulin mesylate (E7389, NSC 707389) in patients with metastatic or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group trial S0618
Susanne M Arnold, James Moon, Stephen K Williamson, et al.
BMJ Open Sport & Exercise Medicine
|
November 2, 2019
Can marathon running improve knee damage of middle-aged adults? A prospective cohort study
Laura Maria Horga, Johann Henckel, Anastasia Fotiadou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 11, 2017
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
Anne S Tsao, James Moon, Ignacio I Wistuba, et al.
Cancer
|
June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007
Francis P Worden, James Moon, Wolfram Samlowski, et al.
Cancer
|
April 10, 2004
A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study
Robert P Whitehead, James Moon, S Spence McCachren, et al.
Plos One
|
December 11, 2012
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512
Shailender Bhatia, James Moon, Kim A Margolin, et al.
Gynecologic Oncology
|
September 18, 2010
Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study
Leslie M Randall, Bradley J Monk, James Moon, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
September 23, 2009
A phase 2 trial of surgery with perioperative INGN 201 (Ad5CMV-p53) gene therapy followed by chemoradiotherapy for advanced, resectable squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, and larynx: report of the Southwest Oncology Group
George H Yoo, James Moon, Michael Leblanc, et al.
Expert Review of Cardiovascular Therapy
|
March 4, 2017
Invasive or non-invasive imaging for detecting high-risk coronary lesions?
Kush Patel, Jason Tarkin, Patrick W Serruys, et al.
Cancer Medicine
|
October 11, 2017
High frequency of brain metastases after adjuvant therapy for high-risk melanoma
Wolfram E Samlowski, James Moon, Merle Witter, et al.
Page
of 14